Skip to content
Shameless Cloning

Search Shameless Cloning

Search superinvestors, stocks, insiders and members of Congress

HELP · ISSUER CIK 1833141

Helus Pharma Inc.

Between Aug 1, 2026 and Oct 29, 2026, 4 Helus Pharma Inc. insiders reported $9.7M of open-market purchases and $0.00 of sales on SEC Form 4. The largest buyer was Glavine Paul (Chief Growth Officer, Director), with $4.7M.

SEC insider filings
↗4 insiders filed

Original Form 4 filings from Aug 1, 2026 to Oct 29, 2026. No open-market sales in the window.

$9.7MInsider buying
$0.00Insider selling
+$9.7MNet open-market
Oct 1, 2026Latest filing
Form 4 trades at Helus Pharma Inc.
TickerInsiderTypeOwned
Oct 1, 202621:16Sep 30, 2026HELPDirectorA · Grant—+248,0004,713,014+6%—
Oct 1, 202620:13Sep 29, 2026HELPChief Financial OfficerP · Buy$12.91+3,0003,000New+$39K-7.9%-17.0%
Oct 1, 202620:12Sep 30, 2026HELPChief Growth Officer, DirectorA · Grant—+248,0004,750,191+6%—
Sep 21, 202617:07Sep 21, 2026HELPChief Executive OfficerP · Buy$13.47+100,000168,568+146%+$1.3M-3.9%-20.5%
Sep 11, 202609:04Sep 8, 2026HELPChief Growth OfficerP · Buy$12.47+100,0004,271,252+2%+$1.2M-10.8%-14.1%
Sep 11, 202609:03Sep 8, 2026HELPChief Growth OfficerP · Buy$12.47+100,0004,271,252+2%+$1.2M-10.8%-14.1%
Sep 11, 202609:01Sep 8, 2026HELPExecutive Chair, DirectorP · Buy$12.39+100,0004,465,014+2%+$1.2M-11.4%-13.5%
Sep 10, 202606:21Sep 4, 2026HELPExecutive Chair, DirectorP · BuyLate 6d$12.09+100,0004,365,014+2%+$1.2M-13.6%-11.4%
Sep 10, 202606:19Sep 3, 2026HELPChief Growth OfficerP · BuyLate 7d$11.78+100,0004,171,252+2%+$1.2M-15.8%-9.1%
Sep 9, 202617:47Sep 1, 2026HELPExecutive Chair, DirectorP · BuyLate 8d$11.81+95,0004,265,014+2%+$1.1M-15.6%-9.3%
Sep 9, 202611:03Aug 31, 2026HELPChief Growth OfficerP · BuyLate 9d$11.59+90,0004,071,252+2%+$1.0M-17.2%-7.6%
Helus Pharma Inc. (HELP) Insider Trading | Shameless Cloning